glp 1 cease and desist The promise peril of GLP-1 agonists: What we do (and don't) know as of August 2024 The promise and peril of
Description
As a coach, you may be wondering: Where do I fit in
Studies of this scale and impact are only possible because of you
Semaglutide is best known as a weight loss drug, yet SELECT was not a weight loss study
A new daily pill called orforglipron helped adults lose weight and improve blood sugar levels in long global trials.
Join us here on youtube and for our weekly podcast where we dive into the good, the bad, and the ugly truths about GLP-1 therapy
